Cargando…
PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells
BACKGROUND: Our previous research results showed that Type II cGMP dependent protein kinase (PKG II) could block the activation of epidermal growth factor receptor (EGFR) and consequently inhibit the proliferation and the related MAPK/ERK-mediated signal transduction of gastric cancer cell line BGC-...
Autores principales: | Jiang, Lu, Lan, Ting, Chen, Yongchang, Sang, Jianrong, Li, Yueying, Wu, Min, Tao, Yan, Wang, Ying, Qian, Hai, Gu, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627897/ https://www.ncbi.nlm.nih.gov/pubmed/23613900 http://dx.doi.org/10.1371/journal.pone.0061674 |
Ejemplares similares
-
The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades
por: Wu, Yan, et al.
Publicado: (2018) -
PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells
por: Wu, Yan, et al.
Publicado: (2016) -
Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway
por: Lan, Ting, et al.
Publicado: (2023) -
Role of PKG II in osteoblast mechanotransduction
por: Rangaswami, Hema, et al.
Publicado: (2009) -
Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
por: Wu, Yan, et al.
Publicado: (2018)